Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages

Journal of Infectious Diseases

Volumn 189, Issue 12, 2004, Pages 2250-2259

  Risso, Marikena G ^a   Garbarino, Gloria B ^a   Mocetti, Esteban ^b   Campetella, Oscar ^b   González Cappa, Stella M ^a   Buscaglia, Carlos A ^b,c   Leguizamon, M Susana ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIALIDASE; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; MORTALITY; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; THYMUS; THYMUS DISEASE; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; VIRUS EXPRESSION; VIRUS SHEDDING;

TRYPANOSOMA CRUZI;

EID: 2942568100     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/420831     Document Type: Article

References (52)

1. World Health Organization (WHO). WHO Technical Report Series. Control of Chagas' Disease. Geneva: WHO, 2002.
2. Leite-de-Moraes MC, Hontebeyrie-Joskowicz M, Dardenne M, Savino W. Modulation of thymocyte subsets during acute and chronic phases of experimental Trypanosoma cruzi infection. Immunology 1992; 77:95-8.
3. Reina-San-Martin B, Cosson A, Minoprio P. Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents. Parasitol Today 2000; 16:62-7.
4. Gao W, Wortis HH, Pereira MA. The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion. Int Immunol 2002; 14:299-308.
5. Tibayrenc M, Ayala FJ. Evolutionary genetics of Trypanosoma and Leishmania. Microbes Infect 1999; 1:465-72.
6. Miles MA, Cedillos RA, Povoa MM, de Souza AA, Prata A, Macedo V. Do radically dissimilar Trypanosoma cruzi strains (zymodemes) cause Venezuelan and Brazilian forms of Chagas' disease? Lancet 1981; 1:1338-40.
7. Dvorak JA. The natural heterogeneity of Trypanosoma cruzi: biological and medical implications. J Cell Biochem 1984; 24:357-71.
8. Tibayrenc M. Genetic epidemiology of parasitic protozoa and other infectious agents: the need for an integrated approach. Int J Parasitol 1998; 28:85-104.
9. Zingales B, Stolf BS, Souto RP, Fernandes O, Briones MR. Epidemiology, biochemistry and evolution of Trypanosoma cruzi lineages based on ribosomal RNA sequences. Mem Inst Oswaldo Cruz 1999; 94(Suppl 1):159-64.
10. Souto RP, Fernandes O, Macedo AM, Campbell DA, Zingales B. DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Mol Biochem Parasitol 1996; 83:141-52.
11. Recommendation from a satellite meeting. Mem Inst Oswaldo Cruz 1999; 94(Supp 1):429-32.
12. Brisse S, Verhoef J, Tibayrenc M. Characterisation of large and small subunit rRNA and mini-exon genes further supports the distinction of six Trypanosoma cruzi lineages. Int J Parasitol 2001; 31:1218-26.
13. Robello C, Gamarro F, Castanys S, Alvarez-Valin F. Evolutionary relationships in Trypanosoma cruzi: molecular phylogenetics supports the existence of a new major lineage of strains. Gene 2000; 246:331-8.
14. Augusto-Pinto L, Teixeira SM, Pena SD, Machado CR. Single-nucleotide polymorphisms of the Trypanosoma cruzi MSH2 gene support the existence of three phylogenetic lineages presenting differences in mismatch-repair efficiency. Genetics 2003; 164:117-26.
15. Machado CA, Ayala FJ. Nucleotide sequences provide evidence of genetic exchange among distantly related lineages of Trypanosoma cruzi. Proc Natl Acad Sci USA 2001; 98:7396-401.
16. Saravia NG, Holguin AF, Cibulskis RE, D'Alessandro A. Divergent isoenzyme profiles of sylvatic and domiciliary Trypanosoma cruzi in the eastern plains, piedmont, and highlands of Colombia. Am J Trop Med Hyg 1987; 36:59-69.
17. Breniere SF, Bosseno MF, Telleria J, et al. Different behavior of two Trypanosoma cruzi major clones: transmission and circulation in young Bolivian patients. Exp Parasitol 1998; 89:285-95.
18. Zingales B, Souto RP, Mangia RH, et al. Molecular epidemiology of American trypanosomiasis in Brazil based on dimorphisms of rRNA and mini-exon gene sequences. Int J Parasitol 1998; 28:105-12.
19. Di Noia JM, Buscaglia CA, De Marchi CR, Almeida IC, Frasch AC. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage. J Exp Med 2002; 195:401-13.
20. Clark CG, Pung OJ. Host specificity of ribosomal DNA variation in sylvatic Trypanosoma cruzi from North America. Mol Biochem Parasitol 1994; 66:175-9.
21. Coura JR, Junqueira AC, Fernandes O, Valente SA, Miles MA. Emerging Chagas disease in Amazonian Brazil. Trends Parasitol 2002; 18:171-6.
22. Cremona ML, Campetella O, Sanchez DO, Frasch AC. Enzymically inactive members of the trans-sialidase family from Trypanosoma cruzi display beta-galactose binding activity. Glycobiology 1999; 9:581-7.
23. Schenkman S, Jiang MS, Hart GW, Nussenzweig V. A novel cell surface traro-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells. Cell 1991; 65:1117-25.
24. Tomlinson S, Pontes de Carvalho LC, Vandekerckhove F, Nussenzweig V. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement. J Immunol 1994; 153:3141-7.
25. Pereira-Chioccola VL, Acosta-Serrano A, Correia de Almeida I, et al. Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-α-galactosyl antibodies. J Cell Sci 2000; 113:1299-307.
26. Saavedra E, Herrera M, Gao W, Uemura H, Pereira MA. The Trypanosoma cruzi trans-sialidase, through its COOH-terminal tandem repeat, upregulates interleukin 6 secretion in normal human intestinal microvascular endothelial cells and peripheral blood mononuclear cells. J Exp Med 1999; 190:1825-36.
27. Todeschini AR, Nunes MP, Pires RS, et al. Costimulation of host T lymphocytes by a trypanosomal trans-sialidase: involvement of CD43 signaling. J Immunol 2002; 168:5192-8.
28. Chuenkova M, Pereira ME. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease. J Exp Med 1995; 181:1693-703.
29. Pereira ME, Zhang K, Gong Y, Herrera EM, Ming M. Invasive phenotype of Trypanosoma cruzi restricted to a population expressing trans-sialidase. Infect Immun 1996; 64:3884-92.
30. Leguizamón MS, Mocetti E, Garcia Rivello H, Argibay P, Campetella O. trans-sialidase from Trypanosoma cruzi induces apoptosis in cells from the immune system in vivo. J Infect Dis 1999; 180:1398-402.
31. Mucci J, Hidalgo A, Mocetti E, Argibay PF, Leguizamón MS, Campetella O. Thymocyte depletion in Trypanosoma cruzi infection is mediated by fram-sialidase-induced apoptosis on nurse cells complex. Proc Natl Acad Sci USA 2002; 99:3896-901.
32. Leguizamón MS, Campetella OE, Gonzalez Cappa SM, Frasch AC. Mice infected with Trypanosoma cruzi produce antibodies against the enzymatic domain of trarcs-sialidase that inhibit its activity. Infect Immun 1994; 62:3441-6.
33. Leguizamón MS, Campetella O, Russomando G, et al. Antibodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections. J Infect Dis 1994; 170:1570-4.
34. Leguizamón MS, Russomando G, Luquetti A, et al. Long-lasting antibodies detected by a trans-sialidase inhibition assay of sera from parasite-free, serologically cured chagasic patients. J Infect Dis 1997; 175:1272-5.
35. González Cappa SM, Mirkin GA, Solana ME, Tekiel VS. Patología por Trypanosoma cruzi: cepa dependiente? Medicina (B Aires) 1999; 59(Suppl 2):69-74.
36. Brener Z. Biology of Trypanosoma cruzi. Annu Rev Microbiol 1973; 27:347-82.
37. Buscaglia CA, Campetella O, Leguizamón MS, Frasch AC. The repetitive domain of Trypanosoma cruzi trans-sialidase enhances the immune response against the catalytic domain. J Infect Dis 1998; 177:431-6.
38. Buchovsky AS, Campetella O, Russomando G, et al. trans-sialidase inhibition assay, a highly sensitive and specific diagnostic test for Chagas' disease. Clin Diagn Lab Immunol 2001;8:187-9.
39. Campetella OE, Uttaro AD, Parodi AJ, Frasch AC. A recombinant Trypanosoma cruzi trans-sialidase lacking the amino acid repeats retains the enzymatic activity. Mol Biochem Parasitol 1994; 64:337-40.
40. Revollo S, Oury B, Laurent JP, et al. Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. Exp Parasitol 1998; 89:30-9.
41. Toledo MJ, de Lana M, Carneiro CM, et al. Impact of Trypanosoma cruzi clonal evolution on its biological properties in mice. Exp Parasitol 2002; 100:161-72.
42. Tibayrenc M, Ayala FJ. The clonal theory of parasitic protozoa: 12 years on. Trends Parasitol 2002; 18:405-10.
43. Su C, Evans D, Cole RH, Kissinger JC, Ajioka JW, Sibley LD. Recent expansion of Toxoplasma through enhanced oral transmission. Science 2003; 299:414-6.
44. Buscaglia CA, Di Noia JM. Trypanosoma cruzi clonal diversity and the epidemiology of Chagas' disease. Microbes Infect 2003; 5:419-27.
45. Leguizamón MS, Campetella OE, Orn A, González Cappa SM. Reversion of culture-induced virulence-attenuation in Trypanosoma cruzi. Mem Inst Oswaldo Cruz 1993; 88:161-2.
46. Vago AR, Andrade LO, Leite AA, et al. Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. Am J Pathol 2000; 156:1805-9.
47. Kawashita SY, Sanson GF, Fernandes O, Zingales B, Briones MR. Maximum-likelihood divergence date estimates based on rRNA gene sequences suggest two scenarios of Trypanosoma cruzi intraspecific evolution. Mol Biol Evol 2001; 18:2250-9.
48. Engel JC, Dvorak JA, Segura EL, Crane MS. Trypanosoma cruzi: biological characterization of 19 clones derived from two chronic chagasic patients. I. Growth kinetics in liquid medium. J Protozool 1982; 29:555-60.
49. Neira I, Ferreira AT, Yoshida N. Activation of distinct signal transduction pathways in Trypanosoma cruzi isolates with differential capacity to invade host cells. Int J Parasitol 2002; 32:405-14.
50. Buscaglia CA, Alfonso J, Campetella O, Frasch AC. Tandem amino acid repeats from Trypanosoma cruzi shed antigens increase the half-life of proteins in blood. Blood 1999; 93:2025-32.
51. de Titto EH, Araujo FG. Serum neuraminidase activity and hematological alterations in acute human Chagas' disease. Clin Immunol Immunopathol 1988; 46:157-61.
52. Chapman MD, Snary D, Miles MA. Quantitative differences in the expression of a 72,000 molecular weight cell surface glycoprotein (GP72) in Trypanosoma cruzi zymodemes. J Immunol 1984; 132:3149-53.